Robert Stoler, MD
Interventional Cardiology · Dallas, TXNPI 1992779839
Payments from drug & device makers
Across 3,590 payments — averaging $2291.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3.9M
- Boston Scientific$2.2M
- Edwards Lifesciences$1.1M
- Biotronik Inc.$461K
- M.a. Med Alliance S.A.$214K
- Shockwave Medical, Inc$210K
- plus $42K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 692 | $3,938,272 |
| Boston Scientific | 458 | $2,247,106 |
| Edwards Lifesciences | 335 | $1,115,042 |
| Biotronik Inc. | 1,919 | $460,951 |
| M.a. Med Alliance S.A. | 36 | $214,472 |
| Shockwave Medical, Inc | 55 | $210,084 |
| Abbott | 13 | $21,565 |
| Siemens Medical Solutions USA, Inc. | 18 | $8,194 |
| Spectrawave, Inc | 6 | $7,532 |
| Teleflex LLC | 13 | $1,605 |
| Cardiva Medical, Inc. | 6 | $491 |
| Penumbra, Inc. | 2 | $296 |
| Novartis | 14 | $240 |
| Recor Medical Inc | 2 | $232 |
| Cardiovascular Systems Inc. | 2 | $225 |
| Opsens Inc. | 1 | $225 |
| GE HealthCare | 2 | $214 |
| Kaneka Medical America LLC | 1 | $181 |
| Corindus Inc. | 1 | $125 |
| Abiomed | 1 | $99 |
| Terumo Medical Corporation | 3 | $66 |
| Johnson & Johnson | 1 | $46 |
| Tactile Systems Technology Inc | 1 | $36 |
| Cathworks, Inc. | 1 | $29 |
| Inari Medical, Inc. | 1 | $25 |
| Saranas, Inc. | 1 | $23 |
| Amgen | 1 | $18 |
| Lantheus Medical Imaging, Inc. | 1 | $16 |
| Itamar Medical Inc | 1 | $13 |
| Novo Nordisk | 1 | $12 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $12 |
How this compares
$8,227,447 in reported general payments places this provider in the 95th percentile of 686 interventional cardiology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Dallas
- James ChoiDallas$5.2M
- Cara Ann EastDallas$3M
- Byung ParkDallas$735K
- Anthony BavryDallas$359K
- Donald WurzburgDallas$341K
- Tony DasDallas$263K
- Zachary RosolDallas$257K
- Srinivasa PotluriPlano$5.1M
- Neal KleimanHouston$4.8M
- Juan GranadaHouston$4.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.